Dr. Charles Fisher is the CEO and Founder of Unlearn(dot)AI which helps in faster drug development and efficient clinical trials. This year they also raised a series B funding of 50 million dollars. Charles holds a Ph.D. in biophysics from Harvard University and prior to founding Unlearn, he did his Postdoctorate at Boston University, followed by being a principal scientist at Pfizer and a machine learning engineer at a virtual reality company in silicon valley.
Time stamps of the conversation 00:00:30 Introduction 00:01:16 What got you into Machine Learning? 00:04:10 Learning the basics and implementation 00:07:55 Digital twins for clinical trials and drug development 00:13:06 Patient heterogeneity in medical research 00:16:05 Error quantification of models 00:17:17 ML models for drug development 00:22:45 Adoption of AI in medical applications 00:25:35 Building trust in AI systems 00:35:10 How to show AI models are safe in real world? 00:38:38 Moving from academia to industry to entrepreneurship 00:45:08 Research projects in startups vs academia vs big companies 00:53:12 Routine as a CEO 00:57:50 Is PhD necessary for a research career in industry? 01:01:20 Taking inspiration from biology to improve machine learning 01:05:25 Advice to young people
***Disclaimer: The information contained in this video represents the views and opinions of the speaker and does not necessarily represent the views or opinions of any institution. It does not constitute an endorsement by any Institution or its affiliates of such video content.***
